BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells
SciencePublished 21 May 1999
Saijun Fan, J.-A. Wang, Ray‐Hwang Yuan, Yanfen Ma, Qinghui Meng, Michael R. Erdos
Citations494
SJR quartileQ1
SJR score10.42
SNIP6.62
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
It is raised the possibility that wild-type BRCA1 suppresses estrogen-dependent transcriptional pathways related to mammary epithelial cell proliferation and that loss of this ability contributes to tumorigenesis.
Abstract
Mutations of the breast cancer susceptibility gene BRCA1 confer increased risk for breast, ovarian, and prostatic cancers, but it is not clear why the mutations are associated with these particular tumor types. In transient transfection assays, BRCA1 was found to inhibit signaling by the ligand-activated estrogen receptor (ER-alpha) through the estrogen-responsive enhancer element and to block the transcriptional activation function AF-2 of ER-alpha. These results raise the possibility that wild-type BRCA1 suppresses estrogen-dependent transcriptional pathways related to mammary epithelial cell proliferation and that loss of this ability contributes to tumorigenesis.
Keywords
Biochemistry, Genetics and Molecular Biology
ScienceA Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene <i>BRCA1</i>
6,105 Citations1994Yoshio Miki, Jeffrey Swensen +43 more
A strong candidate for the 17q-linked BRCA1 gene, which influences susceptibility to breast and ovarian cancer, has been identified by positional cloning methods.
The LancetRisks of cancer in BRCA1-mutation carriers
1,866 Citations1994Daniel Ford
Estimates of breast and ovarian cancer risks are provided which are useful for counselling BRCA1-mutation carriers and carriers are at increased risk of colon and prostate cancer, which may be of clinical significance in certain families if the risks are associated with specific mutations.
CellDynamic Changes of BRCA1 Subnuclear Location and Phosphorylation State Are Initiated by DNA Damage
909 Citations1997Ralph Scully, Junjie Chen +5 more
The data imply that the BRCA1 S phase foci are dynamic physiological elements, responsive to DNA damage, and that B RCA1-containing multiprotein complexes participate in a replication checkpoint response.
CellThe Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse
669 Citations1996Razqallah Hakem, José Luís de la Pompa +13 more
The death of Brca1(5-6) mutant embryos prior to gastrulation may be due to a failure of the proliferative burst required for the development of the different germ layers, and the fact that mutant blastocyst growth is grossly impaired in vitro.
NatureArrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl
508 Citations1997Kumaravel Somasundaram, Hongbing Zhang +8 more
It is shown that BRCA1 transactivates expression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in a p53-independent manner, and that B RCA1 inhibits cell-cycle progression into the S-phase following its transfection into human cancer cells.
ScienceBRCA1 Required for Transcription-Coupled Repair of Oxidative DNA Damage
498 Citations1998Lori C. Gowen, Anna V. Avrutskaya +3 more
It is shown that mouse embryonic stem cells deficient in BRCA1 are defective in the ability to carry out transcription-coupled repair of oxidative DNA damage, and are hypersensitive to ionizing radiation and hydrogen peroxide.
Proceedings of the National Academy of SciencesEvidence for a transcriptional activation function of BRCA1 C-terminal region
443 Citations1996Álvaro N.A. Monteiro, Avery August +1 more
It is shown that the C-terminal region, comprising exons 16-24 (aa 1560-1863) of BRCA1 fused to GAL4 DNA binding domain can activate transcription both in yeast and mammalian cells.
Biology of ReproductionEstrogen Receptors: Bioactivities and Interactions with Cell Signaling Pathways1
377 Citations1996Benita S. Katzenellenbogen
Estrogens and, to a lesser extent, antiestrogens, as well as protein kinase activators and growth factors increase phosphorylation of the ER and possibly other proteins involved in the ER-specific response pathway, suggesting that changes in cellular phosphorylated state will be important in determining the biological activity of theER and the effectiveness of antiestrogen as estrogen antagonists.
Nature GeneticsGrowth retardation and tumour inhibition by BRCA1
358 Citations1996Jeffrey T. Holt, Marilyn E. Thompson +5 more
Proceedings of the National Academy of SciencesE2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.
345 Citations1993E K Flemington, Samuel H. Speck +1 more
It is shown that overexpression of RB, but not the RB mutant, RBd22, can inhibit GAL4/E2F-1 activity in vivo, and this support a model wherein RB suppresses E2f-1-mediated transcriptional activation through direct physical association.
Proceedings of the National Academy of Sciences<i>Brca2</i> is coordinately regulated with <i>Brca1</i> during proliferation and differentiation in mammary epithelial cells
220 Citations1996Jayant V. Rajan, Man Wang +2 more
The results indicate that proliferative stimuli modulate the mRNA expression of these two breast cancer susceptibility genes, Brca1 and Brca2, and suggest that these genes are induced by, and may function in, overlapping regulatory pathways involved in the control of cell proliferation and differentiation.
Molecular and Cellular BiologyAF-2 Activity and Recruitment of Steroid Receptor Coactivator 1 to the Estrogen Receptor Depend on a Lysine Residue Conserved in Nuclear Receptors
213 Citations1997Pirkko Henttu, Eric Kalkhoven +1 more
It is shown that a lysine residue, which is conserved in most nuclear receptors in the predicted helix 3, is also required for estrogen-dependent transactivation, and proposed that it is required, together with residues in helix 12, to form the surface by which members of the nuclear receptor family interact with coactivators.
Molecular and Cellular BiologyInhibition of Cyclin D1 Kinase Activity Is Associated with E2F-Mediated Inhibition of Cyclin D1 Promoter Activity through E2F and Sp1
162 Citations1998Genichi Watanabe, Chris Albanese +5 more
Differential regulation of the cyclin D1 promoter by E 2F-1 and E2F-4 suggests that E2Fs may serve distinguishable functions during cell cycle progression, and inhibition of cyclinD1 abundance by E2f-1 may contribute to an autoregulatory feedback loop to reduce pRB phosphorylation and E1-1 levels in the cell.
Developmental BiologyDevelopmental Expression ofBrca2Colocalizes withBrca1and Is Associated with Proliferation and Differentiation in Multiple Tissues
156 Citations1997Jayant V. Rajan, Sandra T. Marquis +2 more
The spatial and temporal pattern of expression of the murine homologue of BRCA2 during fetal development, in adult tissues, and in the mammary gland during postnatal development is determined and indicates that Brca2 mRNA expression is highest in proliferating cellular compartments, particularly those undergoing differentiation.
CellNuclear Receptors in Sicily: All in the Famiglia
151 Citations1997Thomas Perlmann, Ronald M. Evans
This work described the use of replication-dependent chromatin assembly to identify three regulatory steps in the regulation of transcription by the thyroid hormone receptor (TR) and outlined the general pathway by which the MMTV LTR utilizes a chromatin-based structure to control its transcription.
PubMedInduction of apoptosis by the tumor suppressor protein BRCA1.
139 Citations1996Ning‐Yi Shao, Yingyue Chai +3 more
Since a wide variety of human malignancies like breast and ovarian cancers have a decreased ability to undergo apoptosis, this could be due to lack/decreased levels of functional BRCA1 proteins, treatments that are aimed at increasing the apoptotic threshold by BRCa1 gene therapy may have the potential to prevent the progression of thesemalignancies.
Naturev-Src and EJ Ras alleviate repression of c-Jun by a cell-specific inhibitor
81 Citations1991Vijay Baichwal, Adam Park +1 more
It is shown that cotransfection of the src or ras oncogene enhances the transcriptional activity of a GAL4: c-Jun hybrid that includes the δ-A1 region of c- Jun, suggesting that the DNA binding and dimerization domain of c -Jun is not required for stimulation by Src or Ras.
Critical Reviews™ in OncogenesisRegulation of Estrogen Receptor α Function in Breast Cancer
37 Citations1997Anne Ferguson, Nancy E. Davidson
Current understanding of the mechanisms that regulate ER alpha gene expression and function in breast cancer include alteration of the ER gene, loss of gene expression, alternative splicing of ER RNA, posttranslational modification of the protein, and interaction of ER with other proteins that can modify its function.